
New Cancer Drug Shows Major Win in Biliary Tract Trial
A breakthrough cancer treatment just beat the current standard of care in a major late-stage trial for biliary tract cancer patients. The drug, ivonescimab, helped patients live longer while experiencing fewer side effects than existing treatments.














